Telazorlimab

Telazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases[1].

Product Specifications

CAS Number

[2126777-87-3]

Product Name Alternative

GBR-830

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/telazorlimab.html

Purity

97.00

Solubility

H2O

Smiles

[Telazorlimab]

Molecular Weight

(145.2256 kDa)

References & Citations

[1]Guttman-Yassky E, et, al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Aug;144 (2) :482-493.e7.